In patients who used rivastigmine, the most common side effects included nausea, vomiting, anorexia, dyspepsia and asthenia. These side effects were usually transient and mild to moderate in severity. Adverse reactions were generally less frequent later in the course of treatment. Patients with known hypersensitivity to rivastigmine, other carbamate derivatives or other components of the formulation should not use rivastigmine tartrate. Bone fragility associated with the disease can lead to fractures of the hip, spine and wrist.
Bone fractures are a major cause of morbidity and mortality associated with osteoporosis.
It was previously FDA-labeled for the treatment of moderate to severe vasomotor symptoms associated with menopause and for vulvar and vaginal atrophy associated with menopause. The statement appears in the February 2000 issue of Pediatrics. Because the average office visit lasts 15 minutes or less, many physicians do not have the time or the tools to properly counsel patients on the importance of compliance. The area for health care professionals provides tools for the health care team to use to help patients comply with treatment recommendations. The patient area offers information, tools and tips on better ways to follow appropriate professional advice about medications, diet, exercise and smoking cessation.